The Role of Placebo Control in Clinical Trials for Neurodegenerative Diseases

Overview

Journal Nat Med

Specialties General Medicine
Molecular Biology

Date 2023 Sep 14

PMID 37710137

Authors

Arpan R Mehta

James R Carpenter

Jennifer M Nicholas

Jeremy Chataway

Bruce Virgo

Mahesh K B Parmar

Siddharthan Chandran

Suvankar Pal

Affiliations

Soon will be listed here.

References

Mehta A, Pal S, Chataway J, Carpenter J, Parmar M, Chandran S . Smarter adaptive platform clinical trials in neurology: a showcase for UK innovation. Brain. 2022; 145(8):e64-e65. DOI: 10.1093/brain/awac169. View

Belder C, Schott J, Fox N . Preparing for disease-modifying therapies in Alzheimer's disease. Lancet Neurol. 2023; 22(9):782-783. DOI: 10.1016/S1474-4422(23)00274-0. View

Wong C, Stavrou M, Elliott E, Gregory J, Leigh N, Pinto A . Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective. Brain Commun. 2021; 3(4):fcab242. PMC: 8659356. DOI: 10.1093/braincomms/fcab242. View

Kiernan M, Vucic S, Talbot K, McDermott C, Hardiman O, Shefner J . Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat Rev Neurol. 2020; 17(2):104-118. PMC: 7747476. DOI: 10.1038/s41582-020-00434-z. View

Mehta A, Chataway J, Pal S, Parmar M, Chandran S . Trials for neurodegenerative diseases: time to innovate. Lancet Neurol. 2021; 20(12):984. PMC: 7612114. DOI: 10.1016/S1474-4422(21)00388-4. View

Paganoni S, Berry J, Quintana M, Macklin E, Saville B, Detry M . Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development. Ann Neurol. 2021; 91(2):165-175. DOI: 10.1002/ana.26285. View

Seligmann J, Fisher D, Brown L, Adams R, Graham J, Quirke P . Inhibition of WEE1 Is Effective in - and -Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring. J Clin Oncol. 2021; 39(33):3705-3715. PMC: 8601321. DOI: 10.1200/JCO.21.01435. View

Schoenfeld D, Finkelstein D, Macklin E, Zach N, Ennist D, Taylor A . Design and analysis of a clinical trial using previous trials as historical control. Clin Trials. 2019; 16(5):531-538. PMC: 7008967. DOI: 10.1177/1740774519858914. View

Popat S, Liu S, Scheuer N, Hsu G, Lockhart A, Ramagopalan S . Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer. Nat Commun. 2022; 13(1):3500. PMC: 9205915. DOI: 10.1038/s41467-022-30908-1. View

10.

Quintana M, Saville B, Vestrucci M, Detry M, Chibnik L, Shefner J . Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis. Ann Neurol. 2023; 94(3):547-560. DOI: 10.1002/ana.26714. View